Augmenting engineered T-cell strategies in solid cancers through epigenetic priming-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Augmenting engineered T-cell strategies in solid cancers through epigenetic priming

Published:2020-07-10 Issue:11 Volume:69 Page:2169-2178
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Nielsen Aaraby Y.,Ormhøj Maria,Traynor Sofie,Gjerstorff Morten F.^ORCID

Funder

Kræftens Bekæmpelse

Novo Nordisk Fonden

Danish ministry of health

Natur og Univers, Det Frie Forskningsråd

Fonden til Lægevidenskabens Fremme

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-020-02661-1.pdf

Reference65 articles.

1. Zheng PP, Kros JM, Li J (2018) Approved CAR T cell therapies: ice bucket challenges on glaring safety risks and long-term impacts. Drug Discov Today 23(6):1175–1182

2. Matsuda T, Leisegang M, Park JH, Ren L, Kato T, Ikeda Y et al (2018) Induction of neoantigen-specific cytotoxic T cells and construction of T-cell receptor-engineered T cells for ovarian cancer. Clin Cancer Res 24(21):5357–5367

3. Guedan S, Calderon H, Posey AD Jr, Maus MV (2019) Engineering and Design of Chimeric Antigen Receptors. Mol Ther Methods Clin Dev 12:145–156

4. Carter CA, Oronsky BT, Roswarski J, Oronsky AL, Oronsky N, Scicinski J et al (2017) No patient left behind: the promise of immune priming with epigenetic agents. Oncoimmunology 6(10):e1315486

5. Jones PA, Ohtani H, Chakravarthy A, De Carvalho DD (2019) Epigenetic therapy in immune-oncology. Nat Rev Cancer 19(3):151–161

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies;Recent Patents on Anti-Cancer Drug Discovery;2024-12

2. DNA methyltransferase inhibition promotes recruitment of myeloid-derived suppressor cells to the tumor microenvironment through induction of tumor cell-intrinsic interleukin-1;Cancer Letters;2023-01

3. IFN-γ- and IL-17-producing CD8+ T (Tc17-1) cells in combination with poly-ICLC and peptide vaccine exhibit antiglioma activity;Journal for ImmunoTherapy of Cancer;2021-06

4. Promises and challenges of adoptive T-cell therapies for solid tumours;British Journal of Cancer;2021-03-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3